The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal ...

There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S.

We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing “extremely ...

La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create ...

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically driven forms of excess weight.

The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions ...